These could help identify biological targets for the prevention or treatment of these common diseases and may establish whether certain allelic variants have any effects on other genes, for instance CDKN2A and CDKN2B, since they are the closest to the 9p21 CAD and T2D loci. This evidence concerns the gene CDKN2A and coronary artery disorder.